Lilly to use Dexcom’s CGM devices for personalised diabetes management system
Lilly’s agreement with Dexcom is aimed at developing a complete diabetes management system that integrates connected insulin delivery…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
17 Dec 19
Lilly’s agreement with Dexcom is aimed at developing a complete diabetes management system that integrates connected insulin delivery…
16 Dec 19
t:slim X2 insulin pump is the first FDA approved system to provide automatic correction boluses, apart from facilitating…
13 Dec 19
As a first result of the exclusive negotiations initiated in July, the two companies sign a global distribution…
11 Dec 19
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make…
22 Nov 19
Senseonics has published the assessment of performance of multiple sequential cycles of Eversense 90 and 180-day CGM System…
21 Nov 19
All in-warranty t:slim X2 pump users in Canada will have the option to add Basal-IQ technology to their…
14 Nov 19
Omada has published 11 peer-reviewed studies and is currently running the largest-ever randomized controlled trial of a digital…
28 Oct 19
Fiasp is an ultra fast-acting insulin that enters bloodstream two times faster than Novo Nordisk’s NovoLog
23 Oct 19
Type 2 diabetes is the fastest growing chronic disease in Australia, and Aboriginal and Torre Strait Islander Australians…
16 Oct 19
Abbott and Tandem will sign a final agreement for the technical implementation of device integration and associated commercial…